Archive press release 2014
GKC is delighted to announce that Dr Thomas Lonngren, Swedish regulatory affairs veteran and former Head of European Medicine Agency has been appointed to the GKC Board of Directors.
This appointment is part of an EU expansion agenda for GKC, which coincides with the granting of a key EU patent protecting the company’s ability to record, measure and assess clinical movement data in Parkinson’s patients using the proprietary PKG™ technology. It also secures proprietary mathematical algorithms associated with data analysis.
Please read the full press release here